⌘K

Login Start Free

Home/Filings/4/0001572426-16-000191

4//SEC Filing

Nexvet Biopharma plc 4

Accession 0001572426-16-000191

CIK 0001618561operating

View on SEC.gov Company Profile

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 8:01 PM ET

Size

10.7 KB

Accession

0001572426-16-000191

Insider Transaction Report

Form 4

Period: 2016-06-30

Nexvet Biopharma plcNVET

Director

Transactions

Exercise/Conversion
Ordinary Shares
2016-06-30$0.13/sh+500$63→ 13,400 total
Exercise/Conversion
Ordinary Shares
2016-07-01$0.13/sh+3,600$450→ 17,000 total
Exercise/Conversion
Restricted Share Units
2016-07-01−3,600→ 0 total
Exercise: $0.13From: 2016-07-01Exp: 2020-07-01→ Ordinary Shares (3,600 underlying)
Exercise/Conversion
Restricted Share Units
2016-06-30−500→ 3,500 total
Exercise: $0.13Exp: 2019-07-01→ Ordinary Shares (500 underlying)

Footnotes (1)

[F1]500 of the Restricted Share Units vested and became convertible on 6/30/16, and 500 Restricted Share Units shall vest and become convertible on each of 9/30/16, 12/31/16, 3/31/17, 6/30/17, 9/30/17, 12/31/17 and 3/31/18 in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Nexvet Biopharma plc

CIK 0001618561

Entity typeoperating

IncorporatedIreland

Related Parties

1

filerCIK 0001618561

Filing Metadata

Form type: 4
Filed: Jun 30, 8:00 PM ET
Accepted: Jul 1, 8:01 PM ET
Size: 10.7 KB

View on SEC.gov